Description / Application
Tafamidis is a member of the class of 1,3-benzoxazoles that is 1,3-benzoxazole-6-carboxylic acid in which the hydrogen at position 2 is replaced by a 3,5-dichlorophenyl group. Used (as its meglumine salt) for the amelioration of transthyretin-related hereditary amyloidosis. It has a role as a central nervous system drug. It is a dichlorobenzene, a monocarboxylic acid and a member of 1,3-benzoxazoles. It is a conjugate acid of a tafamidis(1-).
Identities
| Alternative Name | 2-(3,5-Dichlorophenyl)-6-benzoxazole carboxylic acid |
|---|---|
| Molecular Formula | C14H7Cl2NO3 |
| Molecular Weight | 308.1 |
| MFCD | MFCD16621109 |
Safety
| Pictograms |
|
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315;H319;H335 |
| Precautionary Statements | P261;P264;P271;P280;P302+P352;P304+P340;P305+P351+P338;P312;P321;P332+P313;P337+P313;P362;P403+P233;P405;P501 |